Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 17/11/2017
SIETES contiene 92128 citas

 
 
 1 a 20 de 79 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Bromley RL, Weston J, Marson AG. Maternal use of antiepileptic agents during pregnancy and major congenital malformations in children. JAMA 2017;318:1700-1. [Ref.ID 102140]
2. Cita con resumen
Bérard A, Sheehy O, Zhao J-P, Vinet É, Bernatsky S, Abrahamowicz M. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn. Br J Clin Pharmacol 2017;83:1126-33. [Ref.ID 101973]
3. Cita con resumen
Salat D, Llop R, Aguilera C, Danés I, Bosch M, Asensio C, Castañeda F, Esterlich E, Vallano A. Therapeutics enquiries about biological agents as a tool to identify safety aspects and patterns of use. European Journal of Hospital Pharmacy 2016;23:161-5. [Ref.ID 100163]
4. Cita con resumen
Taegtmeyer AB, Curkovic I, Rufibach K, Corti N, Battegay E, Kullak-Ublick GA. Electronic prescribing increases uptake of clinical pharmacologists' recommendations in the hospital setting. Br J Clin Pharmacol 2011;72:958-64. [Ref.ID 91875]
5.Enlace a cita original
Erdeljic V, Francetic I, Makar-Ausperger K, Likic R, Radacic-Aumiler M. Clinical pharmacology consultation: a better answer to safety issues of drug therapy during pregnancy?. Eur J Clin Pharmacol 2010;66:1037-46. [Ref.ID 89445]
6.Enlace a cita original Cita con resumen
Gendron MP, Martin B, Oraichi D, Bérard A. Health care providers' requests to Teratogen Information Services on medication use during pregnancy and lactation. Eur J Clin Pharmacol 2009;65:523-31. [Ref.ID 85831]
7.Enlace a cita original Cita con resumen
Hedegaard U, Damkier P. Problem-oriented drug information: physicians' expectations and impact on clinical practice. Eur J Clin Pharmacol 2009;65:515-22. [Ref.ID 85830]
8.Enlace a cita original Cita con resumen
Frost Widnes SK, Schjott J. Drug use in pregnancy - physician's evaluation of quality and clinical impact of drug information centres. Eur J Clin Pharmacol 2009;65:303-8. [Ref.ID 85449]
9. Cita con resumen
López F, Romans C, Aguilera C. Therapeutic consultation service about teratogens. A pilot study. Basic Clin Pharmacol Toxicol 2006;99:46. [Ref.ID 78400]
10.Enlace a cita original Cita con resumen
Durán M, Pérez E, Ballarín E, Vidal X, Laporte JR, Capellà D. Therapeutic use of cannabis: review and synthesis of the evidence, information, and institutional collaborative research in Catalonia. Basic Clin Pharmacol Toxicol 2006;99:24. [Ref.ID 78388]
11.
Sullivan F, Wyatt JC. Is a consultation needed?. BMJ 2005;331:625-7. [Ref.ID 74813]
12.
13.
von Mach MA, Meyer S, Omogbehin B, Kann PH, Weilemann LS. Epidemiological assessment of 160 cases of insulin overdose recorded in a regional poisons unit. Int J Clin Pharmacol Ther 2004;42:277-80. [Ref.ID 70114]
14.
Eklöf AC, Thurelius AM, Garle M, Rane A, Sjöqvist F. The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology. Eur J Clin Pharmacol 2003;59:571-7. [Ref.ID 68148]
15. Cita con resumen
Haller CA, Anderson IB, Kim SY, Blanc PD. An evaluation of selected herbal reference texts and comparison to published reports of adverse herbal events. Adverse Drug React Toxicol Rev 2002;21:143-50. [Ref.ID 62144]
16. Cita con resumen
Figueras A, Laporte JR. Therapeutic consultation centres are helpful in developing countries. BMJ 2002;324:236. [Ref.ID 60218]
17.
Pedrós C, Agustí A. La consulta farmacoterapéutica como fuente para detectar y prevenir reacciones adversas a medicamentos en el ámbito hospitalario. Archivos de la Facultad de Medicina de Zaragoza 2001;41:21-3. [Ref.ID 56585]
18. Cita con resumen
Brassey J, Elwyn G, Price C, Kinnersley P. Just in time information for clinicians: a questionnaire evaluation of the ATTRACT project. BMJ 2001;322:529-30. [Ref.ID 55395]
19. Cita con resumen
Agustí A, Aguilera C, Danés I, Vidal X, Arnau JM, Laporte JR. La consulta terapèutica: una eina complementària d'informació per a la individualització de la terapèutica. Annals Med (Barc) 2000;83:223-7. [Ref.ID 52594]
20.
Hereu P, Agustí A. Tratamiento antitrombótico en el stent coronario. Med Clin (Barc) 2000;114:113-4. [Ref.ID 49116]
Seleccionar todas
 
 1 a 20 de 79 siguiente >>